|

TRK-950 Clinical Trials

2 actively recruiting trials across 1 location

Pipeline

Phase 2: 1Phase 1/2: 1

Top Sponsors

  • Toray Industries, Inc2

Indications

  • Cancer2
  • Gastroesophageal Junction Adenocarcinoma1
  • Gastric Adenocarcinoma1
  • Melanoma1
  • Solid Tumor1

Other1 trial

A Study of TRK-950 in Patients With Advanced Solid Tumors
Phase 1/2

Duarte, California1 trial

A Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer

City of Hope

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.